Paper Details

  1. Home
  2. Paper Details

Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.

Author: CollinsD, O'ConnorT Z, RobinsS J, RubinsH B, RutanG H, WiltT J

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

This study investigates the prevalence, risk factors, and impact on quality of life associated with combined coronary heart disease and peripheral atherosclerosis. The study highlights the importance of identifying patients with "diffuse atherosclerosis" for targeted treatment and management of modifiable risk factors.
Paper Details　
Original Abstract of the Article :
Peripheral atherosclerosis is a strong and independent predictor of mortality even in patients with known coronary heart disease. However, the prevalence, correlates, and potential adverse effects on quality of life associated with combined coronary heart disease and clinically evident cerebrovascul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8639012

データ提供：米国国立医学図書館（NLM）

Diffuse Atherosclerosis: A Silent Threat

The field of cardiology is constantly seeking a deeper understanding of cardiovascular disease. This research examines the prevalence, correlates, and consequences of diffuse atherosclerosis, a condition characterized by widespread hardening and narrowing of arteries, in men with coronary heart disease. The authors investigated the potential adverse effects of diffuse atherosclerosis on quality of life and overall mortality.

A Silent Threat: Diffuse Atherosclerosis

The study reveals the significant impact of diffuse atherosclerosis on mortality, even in patients with known coronary heart disease. The authors highlight the importance of identifying patients with this condition to enhance risk factor management and implement appropriate therapeutic strategies. They emphasize the need for early detection and intervention to mitigate the detrimental effects of diffuse atherosclerosis.

Preventing Cardiovascular Disease: A Collective Effort

This research underscores the importance of comprehensive cardiovascular risk management. It highlights the need for healthcare professionals to be vigilant in identifying and treating individuals with diffuse atherosclerosis. Patients can play a proactive role in preventing cardiovascular disease by maintaining a healthy lifestyle, controlling risk factors, and adhering to medical advice.

Dr.Camel's Conclusion

This research, like a desert traveler facing a treacherous sandstorm, highlights the hidden dangers of diffuse atherosclerosis. It reminds us that cardiovascular disease is a complex and multifaceted condition that requires vigilant monitoring and proactive management. By understanding the silent threat of diffuse atherosclerosis, we can better equip ourselves to protect our hearts and live longer, healthier lives.

Date :
  1. Date Completed 1996-07-11
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

8639012

DOI: Digital Object Identifier

8639012

Related Literature

Article Analysis
・Effective treatment of atherosclerosis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.